Company / Interest Expense
Oruka Therapeutics, Inc. Interest Expense History
FY2015-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$9.0K
FY2021
5-year range
$7.0K / $9.0K
FY2017-FY2021
Trend
+28.6%
vs FY2020
Sector context
#38 of 44
Health Care
What the data says
Oruka Therapeutics, Inc.'s interest expense of $9,000 is lower than 86% of companies in the Health Care sector (FY2021). Increased from $8,000 to $9,000 over the past 2 years.
Based on SEC 10-K filings.
$9,000 in FY2021 with a 5-year CAGR of +17.6%.
Increased from $8,000 to $9,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +17.6%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $9.0K Sector average $291.0M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.6%, indicating consistent growth.
- In FY2021, interest expense increased 28.6% year-over-year.
- Ranks #38 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $9.0K | +28.6% |
| FY2020 | $7.0K | -12.5% |
| FY2019 | $8.0K | +33.3% |
| FY2018 | $6.0K | +0.0% |
| FY2017 | $6.0K | +50.0% |
| FY2016 | $4.0K | +33.3% |
| FY2015 | $3.0K | -25.0% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026